Research graph
References from A glance through the effects of CD4 + T cells, CD8 + T cells, and cytokines on Alzheimer's disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Distinguishing Alzheimer's disease from other major forms of dementia
10.1586/ern.11.155 · 2011 · External reference
Amyloid β perturbs elevated heme flux induced with neuronal development
10.1016/j.trci.2018.12.003 · 2019 · External reference
The cost of Alzheimer's disease in China and re-estimation of costs worldwide
10.1016/j.jalz.2017.12.006 · 2018 · External reference
The effect of a linear tuning between the antigenic stimulations of CD4+ T cells and CD4+ Tregs
10.3390/math8020293 · 2020 · External reference
A fit of CD4+ T cell immune response to an infection by lymphocytic choriomeningitis virus
10.3934/mbe.2019352 · 2019 · External reference
10.1016/j.thorsurg.2018.12.001
10.1016/j.thorsurg.2018.12.001 · External reference
Unresolved reference
2017 · External reference
10.1038/d41586-017-08280-8
10.1038/d41586-017-08280-8 · External reference
Multiparametric flow cytometry analysis of naïve, memory, and effector T Cells
10.1007/978-1-4939-9650-6_8 · 2019 · External reference
10.1016/j.coi.2011.08.003
10.1016/j.coi.2011.08.003 · External reference
10.1126/science.181845
10.1126/science.181845 · External reference
Toward a precision medicine approach for autoimmunity
10.1073/pnas.2204841119 · 2022 · External reference
10.1146/annurev-med-050715-104343
10.1146/annurev-med-050715-104343 · External reference
10.3390/ijms24087258
10.3390/ijms24087258 · External reference
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
10.1186/s40478-015-0186-2 · 2015 · External reference
10.1155/2020/4356386
10.1155/2020/4356386 · External reference
Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
10.1371/journal.pone.0217216 · 2019 · External reference
T cells make a home in the degenerating brain
2020 · External reference
Inflammatory cytokines in the brain: does the CNS shape immune responses?
10.1016/0167-5699(94)90218-6 · 1994 · External reference
10.1159/000356529
10.1159/000356529 · External reference
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
10.1186/s12974-022-02605-9 · 2022 · External reference
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
10.1016/s0165-5728(01)00496-9 · 2002 · External reference
10.1038/s41586-019-1895-7
10.1038/s41586-019-1895-7 · External reference
10.1016/j.neurobiolaging.2014.08.008
10.1016/j.neurobiolaging.2014.08.008 · External reference
Immune profiling of Alzheimer patients
10.1016/j.jneuroim.2011.11.005 · 2012 · External reference
Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
10.1016/0165-5728(94)90108-2 · 1994 · External reference
T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease
10.1006/clin.1995.1078 · 1995 · External reference
10.1080/08820139.2022.2136525
10.1080/08820139.2022.2136525 · External reference
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
10.1186/s12974-021-02211-1 · 2021 · External reference
Mathematical model on Alzheimer's disease
2016 · External reference
10.1007/s00285-013-0732-0
10.1007/s00285-013-0732-0 · External reference
Alzheimer's disease Neuroimaging Initiative
2018 · External reference
Alzheimer's disease: a mathematical model for onset and progression
2017 · External reference
10.1016/j.brain.2020.100020
10.1016/j.brain.2020.100020 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
2017 · External reference
10.1111/imcb.12301
10.1111/imcb.12301 · External reference
10.3390/ijms24043895
10.3390/ijms24043895 · External reference
10.1056/nejmoa2100708
10.1056/nejmoa2100708 · External reference
10.1016/s0896-6273(03)00294-0
10.1016/s0896-6273(03)00294-0 · External reference
10.1038/nature19323
10.1038/nature19323 · External reference
10.1371/journal.pbio.3001694
10.1371/journal.pbio.3001694 · External reference
10.3390/vaccines10091527
10.3390/vaccines10091527 · External reference
How plausible is an Alzheimer's disease vaccine?
10.1080/17460441.2019.1667329 · 2020 · External reference
10.1023/a:1023203122036
10.1023/a:1023203122036 · External reference
10.1016/s0140-6736(08)61075-2
10.1016/s0140-6736(08)61075-2 · External reference
Are New Alzheimer Drugs Better Than Older Drugs?
10.1001/jamainternmed.2023.3061 · 2023 · External reference
10.1056/nejmoa2212948
10.1056/nejmoa2212948 · External reference
Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease
10.1007/s11033-021-06512-9 · 2021 · External reference
10.1038/s41593-020-00737-w
10.1038/s41593-020-00737-w · External reference
10.1038/s41591-022-01926-9
10.1038/s41591-022-01926-9 · External reference
New roles for Fc receptors in neurodegeneration-the impact on immunotherapy for Alzheimer's disease
10.3389/fnins.2014.00235 · 2014 · External reference
10.1038/35050110
10.1038/35050110 · External reference
10.1111/j.1460-9568.2006.05149.x
10.1111/j.1460-9568.2006.05149.x · External reference
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond
10.1186/s40035-022-00292-3 · 2022 · External reference
Immunotherapy for Alzheimer's disease: hoops and hurdles
10.1186/1750-1326-8-36 · 2013 · External reference
Early active immunization with Aβ3–10-KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice
10.4103/1673-5374.266061 · 2020 · External reference
10.1007/s40263-020-00737-1
10.1007/s40263-020-00737-1 · External reference
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
10.1172/jci200318104 · 2003 · External reference
10.1177/1073858420987224
10.1177/1073858420987224 · External reference
Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease
10.1073/pnas.0506209103 · 2006 · External reference
CD4+ effector T cells accelerate Alzheimer's disease in mice
10.1186/s12974-021-02308-7 · 2021 · External reference
T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer's disease: potential pools of new biomarkers
10.1155/2017/4626540 · 2017 · External reference
CD4 T cells in immunity and immunotherapy of A lzheimer's disease
10.1111/imm.12103 · 2013 · External reference
10.3390/cells11121885
10.3390/cells11121885 · External reference
Innate immune activation in Alzheimer's disease
2018 · External reference
Set back to Alzheimer vaccine studies
10.1038/nm0302-199b · 2002 · External reference
10.1007/s12035-016-0297-1
10.1007/s12035-016-0297-1 · External reference
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
10.1186/s13195-015-0139-9 · 2015 · External reference
Microglial polarization: novel therapeutic strategy against ischemic stroke
10.14336/ad.2020.0701 · 2021 · External reference
10.1007/s10787-019-00613-5
10.1007/s10787-019-00613-5 · External reference
Microglia polarization in Alzheimer's disease: mechanisms and a potential therapeutic target
10.3389/fnagi.2021.772717 · 2021 · External reference
Low-dose ionizing radiation modulates microglia phenotypes in the models of Alzheimer's disease
10.3390/ijms21124532 · 2020 · External reference
10.1016/j.coi.2022.102233
10.1016/j.coi.2022.102233 · External reference
Therapeutic B-cell depletion reverses progression of Alzheimer's disease
10.1038/s41467-021-22479-4 · 2021 · External reference
Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells
10.1186/s40478-015-0251-x · 2015 · External reference
10.1038/356796a0
10.1038/356796a0 · External reference
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
1986 · External reference
A functional dichotomy in CD4+ T lymphocytes
10.1016/0167-5699(88)91308-4 · 1988 · External reference
Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia-and Ia+ helper T cells
10.1084/jem.147.2.446 · 1978 · External reference
10.1038/ni1254
10.1038/ni1254 · External reference
10.1016/j.cyto.2014.09.011
10.1016/j.cyto.2014.09.011 · External reference
Generation and function of induced regulatory T cells
10.3389/fimmu.2013.00152 · 2013 · External reference
Regulatory T cells in multiple sclerosis and myasthenia gravis
10.1186/s12974-017-0892-8 · 2017 · External reference
Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia
10.1177/0300060520976477 · 2020 · External reference
Breast cancer cell–derived il-35 promotes tumor progression via induction of il-35-producing induced regulatory T cells
10.1093/carcin/bgy136 · 2018 · External reference
Maintenance of the human memory T cell repertoire by subset and tissue site
2021 · External reference
Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study
10.1159/000486200 · 2018 · External reference
Interleukin 22 and its association with neurodegenerative disease activity
10.3389/fphar.2022.958022 · 2022 · External reference
The neuroimmune axis of Alzheimer's disease
2023 · External reference
10.1016/s0091-6749(97)70256-2
10.1016/s0091-6749(97)70256-2 · External reference
10.1016/j.yexcr.2019.02.023
10.1016/j.yexcr.2019.02.023 · External reference
10.1016/j.bbi.2010.01.003
10.1016/j.bbi.2010.01.003 · External reference
10.1007/s11481-015-9612-2
10.1007/s11481-015-9612-2 · External reference
Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS
10.1016/j.nbd.2008.12.015 · 2009 · External reference
10.3233/jad-200689
10.3233/jad-200689 · External reference
Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues
2023 · External reference
IL-9 signaling affects central nervous system resident cells during inflammatory stimuli
10.1016/j.yexmp.2015.07.010 · 2015 · External reference
Neuroimmune mechanisms underlying Alzheimer's disease: insights into central and peripheral immune cell crosstalk
2022 · External reference
10.1002/ana.25543
10.1002/ana.25543 · External reference
The roles of IL-22 and its receptor in the regulation of inflammatory responses in the brain
10.3390/ijms23020757 · 2022 · External reference
Neuroprotective effects of CD4+ CD25+ Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model
10.18632/oncotarget.12469 · 2016 · External reference
10.1016/j.jneuroim.2007.05.011
10.1016/j.jneuroim.2007.05.011 · External reference
10.1007/s11481-022-10056-5
10.1007/s11481-022-10056-5 · External reference
10.1016/j.isci.2019.05.039
10.1016/j.isci.2019.05.039 · External reference
10.1177/10738584211024907
10.1177/10738584211024907 · External reference
Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology
10.1038/ncomms8967 · 2015 · External reference
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice
2017 · External reference
10.1093/brain/awv408
10.1093/brain/awv408 · External reference
10.1093/brain/awx108
10.1093/brain/awx108 · External reference
Interleukin-3 prevents neuronal death induced by amyloid peptide
10.1186/1471-2202-8-82 · 2007 · External reference
IL-3 control TAU modifications and protects cortical neurons from neurodegeneration
10.2174/156720510793499011 · 2010 · External reference
The potential for treg-enhancing therapies in nervous system pathologies
10.1093/cei/uxac084 · 2023 · External reference
IL-35 promotes CD4+ Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms
10.1172/jci.insight.152511 · 2021 · External reference
10.1038/gt.2011.126
10.1038/gt.2011.126 · External reference
10.1016/j.neuron.2015.01.021
10.1016/j.neuron.2015.01.021 · External reference
10.3390/biom10071017
10.3390/biom10071017 · External reference
10.1096/fj.10-155317
10.1096/fj.10-155317 · External reference
Analysis of correlation between serum inflammatory factors and cognitive function, language, and memory in alzheimer's disease and its clinical significance
2022 · External reference
Unresolved reference
2012 · External reference
Astrocyte transforming growth factor beta 1 protects synapses against Aβ oligomers in Alzheimer's disease model
10.1523/jneurosci.3351-16.2017 · 2017 · External reference
The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ
10.1186/s40035-016-0054-4 · 2016 · External reference
Role of TGFβ signaling in the pathogenesis of Alzheimer's disease
10.3389/fncel.2015.00426 · 2015 · External reference
TGF-β1 signalling in Alzheimer's pathology and cytoskeletal reorganization: a specialized Tau perspective
10.1186/s12974-023-02751-8 · 2023 · External reference
10.1038/ni.1767
10.1038/ni.1767 · External reference
10.1016/j.bbi.2010.12.004
10.1016/j.bbi.2010.12.004 · External reference
10.1073/pnas.0812530106
10.1073/pnas.0812530106 · External reference
Interleukin-17 in chronic inflammatory neurological diseases
10.3389/fimmu.2020.00947 · 2020 · External reference
Hypoxia enhances stimulating effect of amyloid beta peptide (25–35) for interleukin 17 and T helper lymphocyte subtype 17 upregulation in cultured peripheral blood mononuclear cells
10.1111/j.1348-0421.2009.00120.x · 2009 · External reference
10.1111/bph.14586
10.1111/bph.14586 · External reference
Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease
10.1016/j.phrs.2022.106595 · 2023 · External reference
10.1038/nm.3913
10.1038/nm.3913 · External reference
Low bone density and osteoporosis among older adults with Alzheimer's disease, vascular dementia, and mixed dementia: a cross-sectional study with prospective enrollment
10.5606/tftrd.2020.3803 · 2020 · External reference
Potential association of bone mineral density loss with cognitive impairment and central and peripheral amyloid-β changes: a cross-sectional study
10.1186/s12891-022-05580-7 · 2022 · External reference
TRAP5b and RANKL/OPG predict bone pathology in patients with Gaucher disease
10.3390/jcm10102217 · 2021 · External reference
10.1016/j.lfs.2019.05.006
10.1016/j.lfs.2019.05.006 · External reference
10.1016/j.bbi.2017.05.012
10.1016/j.bbi.2017.05.012 · External reference
10.1016/j.bbi.2015.11.005
10.1016/j.bbi.2015.11.005 · External reference
IL-17 receptor signaling in osteoblasts/osteocytes mediates PTH-induced bone loss and enhances osteocytic RANKL production
10.1002/jbmr.3600 · 2019 · External reference
10.1016/j.immuni.2008.07.018
10.1016/j.immuni.2008.07.018 · External reference
Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response
10.3389/fimmu.2017.00254 · 2017 · External reference
10.4049/jimmunol.1000142
10.4049/jimmunol.1000142 · External reference
10.7150/ijbs.4679
10.7150/ijbs.4679 · External reference
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease
10.1038/s41398-021-01349-z · 2021 · External reference
Role of IL-6 in the regulation of neuronal development, survival and function
10.1016/j.cyto.2021.155582 · 2021 · External reference
Association of peripheral interleukin-6 with global cognitive decline in non-demented adults: a meta-analysis of prospective studies
10.3389/fnagi.2017.00438 · 2018 · External reference
10.1016/j.jpsychires.2021.02.007
10.1016/j.jpsychires.2021.02.007 · External reference
Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study
10.1016/j.heliyon.2023.e13972 · 2023 · External reference
10.1016/j.jneuroim.2018.09.002
10.1016/j.jneuroim.2018.09.002 · External reference
Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model
10.1007/s11010-016-2762-6 · 2016 · External reference
Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
10.1096/fj.09-141754 · 2010 · External reference
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease
2021 · External reference
10.1016/j.bbi.2019.08.005
10.1016/j.bbi.2019.08.005 · External reference
10.1084/jem.186.9.1407
10.1084/jem.186.9.1407 · External reference
10.1016/j.bbi.2020.05.070
10.1016/j.bbi.2020.05.070 · External reference
Crossing borders in Alzheimer's disease: a T cell's perspective
2022 · External reference
T cells in Alzheimer's disease: space invaders
10.1016/s1474-4422(20)30076-4 · 2020 · External reference
10.1007/s00018-019-03132-2
10.1007/s00018-019-03132-2 · External reference
10.1093/brain/aww270
10.1093/brain/aww270 · External reference
Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice
10.1186/s12974-018-1304-4 · 2018 · External reference
10.3233/jad-210607
10.3233/jad-210607 · External reference
10.1038/s41586-023-05788-0
10.1038/s41586-023-05788-0 · External reference
Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease
10.3233/jad-2009-1015 · 2009 · External reference
The Trojan horse-neuroinflammatory impact of T cells in neurodegenerative diseases
10.1186/s13024-017-0222-8 · 2017 · External reference
Could Alzheimer's disease originate in the periphery and if so how so?
10.1007/s12035-018-1092-y · 2019 · External reference
The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age
10.1007/s10522-008-9138-6 · 2008 · External reference
Association of peripheral blood cell profile with Alzheimer's disease: a meta-analysis
10.3389/fnagi.2022.888946 · 2022 · External reference
The decrease of CD8-positive lymphocytes in Alzheimer's disease
10.1016/0022-510x(92)90284-r · 1992 · External reference
Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease
10.1055/s-2006-954591 · 2006 · External reference
Altered lymphocyte distribution in Alzheimer's disease
10.1016/j.jpsychires.2006.01.010 · 2007 · External reference
The Innate and adaptive immune cells in Alzheimer's and Parkinson's Diseases
10.1155/2022/1315248 · 2022 · External reference
Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes
10.1007/s12035-012-8300-y · 2012 · External reference
Application of artificial intelligence modeling technology based on fluid biopsy to diagnose alzheimer's disease
10.3389/fnagi.2021.768229 · 2021 · External reference
Ribosomal proteins are blood biomarkers and associated with CD4+ T cell activation in Alzheimer's disease: a study based on machine learning strategies and scRNA-Seq data validation
2023 · External reference
10.3390/ijms22010294
10.3390/ijms22010294 · External reference
Mechanisms of natural food dyes curcumin on regulation of HO-1/HO-2 and inhibition of Aβ-Heme compound in Alzheimer's disease
10.4028/www.scientific.net/amr.781-784.1148 · 2013 · External reference
10.3390/biomedicines11051387
10.3390/biomedicines11051387 · External reference
Arsenic induces blood-brain barrier disruption and regulates T lymphocyte subpopulation differentiation in the cerebral cortex and hippocampus associated with the Nrf2 pathway in vivo
10.1007/s12011-022-03500-3 · 2023 · External reference
Unresolved reference
External reference
10.1073/pnas.96.5.2445
10.1073/pnas.96.5.2445 · External reference
Heme oxygenase-2 is post-translationally regulated by heme occupancy in the catalytic site
10.1074/jbc.ra120.014919 · 2020 · External reference
10.1016/j.ejmech.2019.111703
10.1016/j.ejmech.2019.111703 · External reference
Heme oxygenase-2 suppresses acute inflammation and improves the survival of skin allografts
10.1016/j.intimp.2018.08.009 · 2018 · External reference
10.1080/10408398.2017.1358139
10.1080/10408398.2017.1358139 · External reference
Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production
10.4049/jimmunol.172.8.4744 · 2004 · External reference
Differential expressions of heme oxygenase-1 gene in CD25− and CD25+ subsets of human CD4+ T cells
10.1016/s0006-291x(03)01037-4 · 2003 · External reference
10.4049/jimmunol.0903127
10.4049/jimmunol.0903127 · External reference
Heme oxygenase-1-expressing dendritic cells promote Foxp3+ regulatory T cell differentiation and induce less severe airway inflammation in murine models
10.1371/journal.pone.0168919 · 2016 · External reference
Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases
10.3389/fimmu.2020.01467 · 2020 · External reference
10.3233/jad-200720
10.3233/jad-200720 · External reference
CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease
10.1016/j.bbrc.2018.05.101 · 2018 · External reference
10.1016/j.pneurobio.2018.06.008
10.1016/j.pneurobio.2018.06.008 · External reference
Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice
10.3233/jad-140567 · 2015 · External reference
10.3233/jad-180451
10.3233/jad-180451 · External reference
10.3233/jad-150027
10.3233/jad-150027 · External reference
Unresolved reference
2016 · External reference
10.1021/acs.accounts.5b00102
10.1021/acs.accounts.5b00102 · External reference
10.3390/ijms19082260
10.3390/ijms19082260 · External reference
10.1089/ars.2022.0214
10.1089/ars.2022.0214 · External reference
10.1038/cddis.2014.529
10.1038/cddis.2014.529 · External reference
Carbon monoxide attenuates amyloidogenesis via down-regulation of NF-κB-mediated BACE1 gene expression
10.1111/acel.12864 · 2019 · External reference
10.3390/antiox9121214
10.3390/antiox9121214 · External reference
Biological and pharmacological properties of carbon monoxide: a general overview
10.3390/oxygen2020012 · 2022 · External reference
Carbon monoxide-Neuroglobin axis targeting metabolism against inflammation in BV-2 microglial cells
2022 · External reference
Unresolved reference
2012 · External reference
Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation
10.1007/s00011-015-0834-9 · 2015 · External reference
Carbon monoxide releasing molecule-3 enhances heme oxygenase-1 induction via ROS-dependent FoxO1 and Nrf2 in brain astrocytes
2021 · External reference
Nrf2: a dark horse in Alzheimer's disease treatment
10.1016/j.arr.2020.101206 · 2020 · External reference
10.3390/antiox10071069
10.3390/antiox10071069 · External reference
Nrf2 ablation promotes Alzheimer's disease-like pathology in APP/PS1 transgenic mice: the role of neuroinflammation and oxidative stress
2020 · External reference
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
10.1016/j.redox.2017.07.006 · 2017 · External reference
A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer's and Parkinson's diseases
10.3389/fncel.2021.787258 · 2022 · External reference
10.3390/ijms18122772
10.3390/ijms18122772 · External reference
Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8+ T cell function by limiting GSH and Cys availability
10.1016/j.freeradbiomed.2015.02.004 · 2015 · External reference
Activated bone marrow-derived macrophages eradicate Alzheimer's-related Aβ42 oligomers and protect synapses
10.3389/fimmu.2020.00049 · 2020 · External reference
The role of mitochondrial dysfunction in the progression of Alzheimer's disease
10.2174/0929867324666170616110111 · 2018 · External reference
Mechanisms of mitochondrial dysfunction in Alzheimer's disease
10.1007/s12035-015-9515-5 · 2016 · External reference
The association of tau with mitochondrial dysfunction in Alzheimer's disease
10.3389/fnins.2018.00163 · 2018 · External reference
10.1172/jci120848
10.1172/jci120848 · External reference
10.1083/jcb.201709172
10.1083/jcb.201709172 · External reference
10.1016/j.immuni.2012.10.020
10.1016/j.immuni.2012.10.020 · External reference
10.1038/nm.3758
10.1038/nm.3758 · External reference
10.1016/j.freeradbiomed.2020.12.009
10.1016/j.freeradbiomed.2020.12.009 · External reference
10.1016/j.cmet.2014.05.004
10.1016/j.cmet.2014.05.004 · External reference
10.1038/s41583-019-0132-6
10.1038/s41583-019-0132-6 · External reference
10.1016/j.freeradbiomed.2022.09.032
10.1016/j.freeradbiomed.2022.09.032 · External reference
Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain
10.1016/j.mad.2016.05.005 · 2017 · External reference
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer's disease
10.1007/s10072-019-03863-x · 2019 · External reference
Effects of mitochondrial dysfunction on the immunological properties of microglia
10.1186/1742-2094-7-45 · 2010 · External reference
Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases
10.3389/fncel.2018.00114 · 2018 · External reference
Mitochondrial depletion in CD4+ and CD19+ peripheral lymphocytes in early stage Alzheimer's disease
10.1016/j.mad.2017.09.003 · 2017 · External reference
Mitochondrial dysfunction in CD4+ T effector memory RA+ cells
10.3390/biology12040597 · 2023 · External reference
p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells
10.1172/jci75051 · 2014 · External reference
IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca2+ through the noncanonical STAT3 pathway
10.1073/pnas.2103444118 · 2021 · External reference
10.18632/aging.102438
10.18632/aging.102438 · External reference
10.1002/1873-3468.12890
10.1002/1873-3468.12890 · External reference
10.1038/nri.2017.66
10.1038/nri.2017.66 · External reference
10.1111/febs.15327
10.1111/febs.15327 · External reference
10.1038/s41590-020-0725-2
10.1038/s41590-020-0725-2 · External reference
Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging
10.1073/pnas.192585799 · 2002 · External reference
A transcriptome-wide association study of Alzheimer's disease using prediction models of relevant tissues identifies novel candidate susceptibility genes
2021 · External reference
Genome-wide association studies for Alzheimer's disease: bigger is not always better
10.1093/braincomms/fcac125 · 2022 · External reference
10.1038/s41588-018-0311-9
10.1038/s41588-018-0311-9 · External reference
Detecting diagnostic biomarkers of Alzheimer's disease by integrating gene expression data in six brain regions
10.3389/fgene.2019.00157 · 2019 · External reference
Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease
10.3389/fimmu.2023.1182307 · 2023 · External reference
Identification of diagnostic signatures associated with immune infiltration in Alzheimer's disease by integrating bioinformatic analysis and machine-learning strategies
10.3389/fnagi.2022.919614 · 2022 · External reference
Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer's disease based on interpretable machine learning
10.3389/fphar.2022.975774 · 2022 · External reference
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
10.3389/fnagi.2022.932676 · 2022 · External reference
10.1177/1073858420908189
10.1177/1073858420908189 · External reference
10.1093/jalm/jfaa171
10.1093/jalm/jfaa171 · External reference
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
10.1002/trc2.12283 · 2022 · External reference
Unresolved reference
2022 · External reference
10.1038/90950
10.1038/90950 · External reference
